A cross sectional analysis of the patient cohort monitored by the FLOW blood monitoring tool in a large Irish multiple sclerosis centre (PDF, 185KB)
Jordan S, McKiernan PJ, McGuigan C.
Adherence to physical rehabilitation delivered via telerehabilitation for people with Multiple Sclerosis (PDF, 240KB)
Goldsmith G, Bollen J , Salmon V, Freeman J, and Dean S.
An occupational therapy perspective on the prescription of Sativex (PDF, 595KB)
Staszewski A.
Comparing the impact of dose titration on gastrointestinal tolerability (PDF, 155KB)
Naismith RT, Badwan R, Chen H, Lyons J, et al.
Continuing professional development (CPD) with the MS Trust (PDF, 435KB)
Naik P.
Diroximel Fumarate in patients with relapsing-remitting multiple sclerosis (PDF, 240KB)
Wray S, Singer BA, Drulovic J, Chen H, et al.
Discordance between neurologists and people living with multiple sclerosis on the perception of the presence and Burden of cognitive impairment (PDF, 510KB)
Penner IK, De Las Heras V, Jones E, Ryan S et al.
Evaluation of the satisfaction and value of YourMS questionnaire in supporting patient-healthcare professional consultation (PDF, 329KB)
Panesar P, Bowers B, Carod Artal J, Fisniku L, et al.
Feedback from online MS exercise classes (PDF, 700KB)
Douglas L, Koch M, Broome K, and Wilkinson H.
Flushing and flushing related adverse events with Diroximel Fumarate in patients with relapsing remitting multiple sclerosis (PDF, 170KB)
Singer BA, Faissner S, Lyons J, Scaramozza M, et al.
Hereford MS wellbeing hub (PDF, 425KB)
Thomas D, Evans E, and Jones C.
"Hurled into it at the great speed of almighty": Remote assessments of physical impairments during the Covid-19 pandemic (PDF, 645KB)
Freeman J, Buckingham S, Anil K, Demain S, et al.
Move while you wait: Delivering remote exercise education to those on the physiotherapy waiting list at the NHNN (PDF, 300KB)
Koch M, Wilkinson M, Broome K, Juckes F, and Cavalla A.
MS nurse PROfessional 2012–2022: A vision of MS nursing excellence (PDF, 2MB)
Jarrett L.
Patient experience of starting treatment with Kesimpta (Ofatumumab) for RRMS (PDF, 485KB)
Slough J, and Barker N.
Patient feedback survey on the subcutaneous injection (SC) for Natalizumab (Tysabri) (PDF, 340KB)
Ayer M, Cacdac D, and Nash C.
Patient-reported outcomes measures for multiple sclerosis (PDF, 570KB)
Chitnis T, Bharadia T, Brichetto G, Lloyd A et al.
Sativex for spasms and spasticity in MS: Patient selection and outcomes in Cardiff and Vale and Cwm Taff (PDF, 140KB)
Lowman A, and O'Halloran R.
Supporting clinical skills and confidence for MS nurse specialists when discussing bladder dysfunction (PDF, 330KB)
Maddams T, Parker J, and Riding M.
Supporting patients with life limiting neurological illness in a pandemic: Service evolution (PDF, 840KB)
Teed H, Kelly C, Campbell J, and Isherwood R.
The lived experience of physical exertion for persons living with advanced multiple sclerosis (PDF, 285KB)
Bassett B, and Hebron C.
The pelvic flaw: Co-producing pelvic health physiotherapy with women with multiple sclerosis (PDF, 385KB)
Addington C, Bradshaw A, Hagen S, and McClurg D.
The UK MS pregnancy register: Baseline data from the first 50 participants (PDF, 375KB)
White S, Macleod N, Brex P, Ford H, et al.
Treatment approaches in relapsing-remitting multiple sclerosis (RRMS): a survey of clinicians in the United Kingdom (PDF, 250KB)
Coutts M, Evangelou N, Mattoscio M, Andiappan M et al.
Understanding the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis (PDF, 325KB)
Rog D, Brownlee W, Carod-Artal FJ, Kalra S, et al.
Updating guidelines for management of the MS Bladder – a consensus group approach (PDF, 115KB)
Young J, Bradley J, and Thomas S.
